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Abstract 
Little is known about the aetiology of childhood brain tumours. We investigated anthropometric 
factors (birth weight, length, maternal age), birth characteristics (e.g. vacuum extraction, preterm 
delivery, birth order) and exposures during pregnancy (e.g. maternal: smoking, working, dietary 
supplement intake) in relation to risk of brain tumour diagnosis among 7–19 year olds. The 
multinational case-control study in Denmark, Sweden, Norway and Switzerland (CEFALO) 
included interviews with 352 (participation rate=83.2%) eligible cases and 646 (71.1%) 
population-based controls. Interview data were complemented with data from birth registries and 
validated by assessing agreement (Cohen’s Kappa). We used conditional logistic regression 
models matched on age, sex and geographical region (adjusted for maternal age and parental 
education) to explore associations between birth factors and childhood brain tumour risk. 
Agreement between interview and birth registry data ranged from moderate (Kappa=0.54; 
worked during pregnancy) to almost perfect (Kappa=0.98; birth weight). Neither anthropogenic 
factors nor birth characteristics were associated with childhood brain tumour risk. Maternal 
vitamin intake during pregnancy was indicative of a protective effect (OR 0.75, 95%-CI: 
0.56˗1.01). No association was seen for maternal smoking during pregnancy or working during 
pregnancy. We found little evidence that the considered birth factors were related to brain tumour 
risk among children and adolescents.  
 
Key words: Brain tumours; children; adolescents; pregnancy; validation 
4 
 
INTRODUCTION 
Primary central nervous system (CNS) neoplasms, of which >90% are located in the brain, are 
the second most common malignancy and the most common solid cancer in children in 
developed countries.1 While brain tumours during childhood often occur before the age of five, 
suggesting that both prenatal and early postnatal exposures must be considered, it remains one of 
the most common childhood cancers across the whole child-adolescent age spectrum.2 The 
annual incidence rate of CNS tumours in children aged 0-14 years is 30 per million in Europe,3 
35 per million in Switzerland4 and 42 per million in the Nordic countries. 5  
Despite decades of epidemiological research, the aetiology of primary brain tumours in children 
and adolescents largely remains unknown.6 Apart from ionizing radiation and a few genetic 
syndromes such as neurofibromatosis and tuberous sclerosis, no risk factors have been 
identified.7 Many potential risk factors, however, have been studied including head injuries,8 
maternal and paternal smoking,9, 10 maternal diet (especially cured meat),11 maternal age and birth 
characteristics such as birth weight or birth order,12, 13 atopy,14 exposure to infectious agents,15, 16 
exposure to pesticides,17 parental occupation,18 maternal medication and vitamin intake during 
pregnancy19, 20 and electromagnetic fields from mobile phones.21 Most of these studies yielded 
inconclusive and conflicting results and often faced methodological limitations. The established 
risk factors collectively account for only 5% of all brain tumours in children7 and a recent study 
estimated that the majority of cancer risk is due to random mutations due to cell division ˗ only 
one third of the variance in cancer risk for tissues was attributable to environmental or inheritance 
factors.22    
We investigated several anthropometric factors, birth characteristics and exposures during 
pregnancy in relation to brain tumour diagnosis among children and adolescents aged 7–19 using 
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data from CEFALO, a multinational case-control study conducted in Denmark, Sweden, Norway 
and Switzerland. We validated the interview data with data from the birth registries to evaluate 
recall bias and exposure misclassification. 
MATERIALS AND METHODS 
Study population 
Cases 
Eligible cases were all children in Denmark, Sweden, Norway and Switzerland diagnosed 
between 2004 and 2008 with primary intracranial central nervous system tumours (CNS) aged 7 
to 19 years at diagnosis.21 Brain tumours were defined as per the International Classification of 
Diseases tenth revision (ICD-10) and International Classification of Diseases for Oncology third 
edition (ICD-O-3). All diagnoses were either histologically confirmed or based on unequivocal 
diagnostic imaging. We examined medical records for case patients to confirm diagnosis and 
establish the date of diagnosis (used as reference date in the exposure assessment). Date of 
diagnosis was defined as the date when the first diagnostic imaging was performed. Case patients 
were excluded if they were diagnosed with neurofibromatosis (Mb Recklinghausen; 12 patients) 
or tuberous sclerosis (1 patient). Since the initial hypothesis of CEFALO was on the use of 
mobile phones, participants who were completely deaf prior to the reference date and children 
with severe mental retardation were excluded (2 patients and 2 control subjects). Families with 
insufficient language skills to complete an interview in the respective country, as judged by a 
nurse, treating physician, or project administrator, were excluded (15 patients and 36 control 
subjects). 
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Controls 
We randomly selected two control subjects per case patient using population registries in the 
participating countries, individually matched by age (Denmark, Sweden, and Switzerland: by 
year and month of birth; Norway: by year of birth), sex, country, and geographical region within 
country. In Switzerland, a two-stage random sampling procedure was applied in the absence of a 
national population registry. A community was randomly determined within the same language 
region as each patient, next the control subject was randomly selected from the corresponding 
communal population registry. The reference date for control subjects was same as the date of 
diagnosis of the matched case patient. 
Data collection 
Children were accompanied by at least one parent (preferably the mother) and were interviewed 
face-to-face by trained interviewers using a computer-assisted personal interview (CAPI) 
questionnaire (Denmark and Norway) or a paper version of the questionnaire (Switzerland and 
Sweden). In exceptional circumstances, telephone interviews were conducted with difficult-to-
reach participants (4 control subjects) or an adapted paper version of the questionnaire was sent 
(19 control subjects). Interviews with case patients and matched control subjects were mainly 
performed by the same interviewer. Interviewers from all centres received training at a joint 
workshop to ensure uniform data collection. Questionnaire translations were checked through 
back-translation to the master version (English), and the questionnaires were pilot-tested in all 
participating countries. 
All case patients were interviewed within 5 years of diagnosis (63% within 2 years). The 
accompanying parent responded to questions related to pregnancy and early life exposures.   
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Exposure information 
Interview questions were aimed at collecting both infant as well as parental characteristics. 
Anthropometric factors were birth weight, birth length, and age of the mother (<25, 25–34, ≥35 
years). Birth characteristics were Caesarean section (yes, no), vacuum extraction (yes, no), use of 
obstetrical forceps (yes, no), if the child was born premature (i.e. ≥3 weeks early; yes, no), birth 
order of the child in the family (1st born, later born), and if the mother ever had a miscarriage or 
a stillbirth (yes, no). We considered the following variables as exposures: maternal smoking 
during pregnancy (yes, no), maternal vitamin intake during pregnancy (yes, no), maternal intake 
of vitamins with folic acid (yes, no), working during pregnancy (yes, no), hours worked during 
pregnancy (full-time, part-time, not worked), shift work during pregnancy (yes, no), and maternal 
diabetes during pregnancy (yes, no). 
In addition to the CEFALO questionnaire, supplementary data from national birth registries in 
Sweden, Denmark and Norway were obtained. Registry data were not available for Switzerland. 
For anthropometric factors we obtained birth weight, birth length, head circumference and 
gestational age in weeks. Birth characteristics comprised Caesarean section (yes, no), vacuum 
extraction (yes, no), use of obstetrical forceps (yes, no), ever stillbirth or miscarriage (yes, no), 
single or multiple births (singleton, multiple birth) and parity (first born, not first born). Specific 
exposures during pregnancy related to maternal smoking at first visit to maternity clinic (yes, no), 
working during pregnancy (yes, no) and hours worked during pregnancy (full-time, part-time, not 
worked).  
Statistical analysis 
Agreement between interview data and data from the birth registries was calculated by Cohen’s 
Kappa.23 Weighted Kappa was used for variables with more than two categories. We considered 
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agreement to be moderate if the Kappa value was 0.4-0.6, substantial for 0.6-0.8, and almost 
perfect >0.8. 
Odds ratios (ORs) and 95%-confidence intervals (95%-CIs) to estimate the strength and precision 
of association between the possible risk factors and brain tumour risk were based on conditional 
logistic regression models matched on age, sex, and geographical region. We additionally 
adjusted for maternal age and parental education. To gap fill missing confounder information: we 
applied the most common category for parental education (n=3); and for maternal age (n=11) we 
imputed missing values based on age of the child, paternal age, country and region. All statistical 
tests were two-sided. For categorical variables, test for trends were calculated by assigning 
ordered exposure levels (e.g., 1, 2, 3). We assessed the risk for all histologic types of brain 
tumours combined, and specifically for astrocytoma, where numbers were large enough to allow 
a subgroup analysis. 
The software Stata/SE version 13.0 (StataCorp, Texas, USA) was used for all analyses. 
RESULTS 
In total, 423 patients and 909 potential controls were identified during the CEFALO study period. 
Interviews were completed with 352 (83.2%) eligible cases and 646 (71.1%) eligible controls 
(Table 1). Among the 352 case patients of CNS cancer, astrocytoma was the most common type 
with 162 (46.0%) cases (Table 1). There were 21 (6.0%) cases diagnosed with ependymoma, 30 
(8.5%) with another glioma, 62 (17.6%) with primitive neuroectodermal tumours, 53 (15.1%) 
with other specified intracranial neoplasms and 24 (6.8%) with unspecified intracranial 
neoplasms. 
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The agreement between data reported in the interview and data collected from the birth registries 
ranged from moderate (Kappa=0.54 for worked and hours worked during pregnancy) to almost 
perfect (Caesarean section, birth weight and whether or not the child was a singleton; Table 2). 
Although some Kappa coefficients were marginally higher in cases, there was no evidence of a 
systematic difference between cases and controls.  
Results for the association between reported anthropometric factors, birth characteristics and 
exposures during pregnancy and the risk of all brain tumours among children and adolescents are 
shown in Table 3; Table S1 (online supplement) shows results for the analysis restricted to 
astrocytoma cases. We found no evidence for an increased risk of brain tumours for any of the 
anthropometric factors. Children with a brain tumour were not more likely to have had a birth 
weight ≥4000g compared to controls. Birth characteristics, such as intervention during birth or 
prematurity, did not alter the risk of being diagnosed with a brain tumour. Odds ratios seemed to 
fluctuate around unity and no clear tendency was seen for any of the considered birth 
characteristics. 
Maternal vitamin intake during pregnancy was indicative, though not statistically significant, of a 
protective effect for childhood brain tumours (adjusted OR 0.75, 95%-CI: 0.56˗1.01; Table 3). No 
association, however, was observed in the subset of mothers who indicated that their vitamin 
supplements contained folic acid (Table 1), or in patients with astrocytoma (Table S1). All other 
considered exposures, such as work during pregnancy and maternal diabetes (i.e. existing 
maternal diabetes or maternal gestational diabetes), indicated no increased risk. Analyses 
restricted to astrocytoma (Table S1) gave broadly similar results compared to the full sample.   
Table 4 reports the associations based on data collected in the birth registries, and compares the 
estimates with interview based exposure data for the same study sample (without Switzerland). 
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We found no evidence for an increased risk of brain tumours for any of the measures evaluated in 
the birth registries. Risk estimates were similar for birth registry and interview data for all 
variables except smoking where risk estimates slightly above unity were observed for interview 
data vs. close to unity for the registry data. The 95%-confidence intervals, however, were 
overlapping to a large extent. Regarding risk of astrocytoma, we saw evidence of a protective 
effect of working during pregnancy (adjusted OR 0.14, 95%-CI: 0.02˗0.97) and specifically for 
part-time work during pregnancy (adjusted OR 0.09, 95%-CI: 0.01˗0.97), though only in a small 
sample with interview data (Table S2). 
DISCUSSION 
The relationship between pre- and postnatal characteristics and exposures and the risk of 
childhood brain tumours has been investigated in many studies, often with inconclusive results.12, 
24-29 A birth weight ≥4000g has been repeatedly associated with an increased risk for childhood 
brain tumours and other cancers.28, 30 In a meta-analysis by Harder, et al. 31 including 1.7 mil 
children and ~4000 cases, the odds ratios for the relationship between high birth weight and 
childhood brain tumours were 1.38 (95%-CI: 1.07˗1.79) and 1.27 (95%-CI: 1.02˗1.60), 
respectively for medulloblastoma and astrocytoma. We observed no such association in our study 
population for astrocytoma risk and birth weight from interview or registry data (Table S1 and 
S2). Our sample of children with a birth weight ≥4000g, however, was relatively small and the 
statistical power to detect an association was limited. Furthermore, since the primary aim of 
CEFALO was to address the  risk from mobile phone use,21 our age range of 7-19 years was 
different to that of most other studies, usually focussed on 0-14 year olds, and the association 
with prenatal factors may be stronger in the youngest children as shown in Schmidt, et al. 28 In 
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addition, we found no indication that birth length, head circumference or maternal age at birth 
alters the risk of childhood brain tumours. 
We found a tendency that children whose mother reported to have smoked during pregnancy had 
a higher risk of brain tumours compared to children of non-smoking mothers (Table 3). This 
tendency, however, was not apparent when we looked at the association using registry-recorded 
smoking status (Table 4). The relationship between maternal smoking and childhood brain 
tumour risk has been reported by a few studies10 , 32 but most found no evidence for an 
association.9, 24 , 29, 33, 34 , 35 A meta-analysis found an overall risk estimate of 1.05 (95%-CI: 
0.90˗1.21).36 Most of these studies were case-control studies that assessed the exposure 
retrospectively raising the question of recall bias. Recall bias could potentially be in both 
directions. Case mothers may over-report their smoking during pregnancy because they consider 
smoking a relevant risk factor to report. Or they may under-report because they do not want to be 
accused of having done harm to their child. A particular strength of our study is that we used 
prospectively collected smoking data, from the birth registry, which cannot suffer from recall 
bias. We found similar agreement between interview and registry data for cases and controls 
(Table 2), although the false positive rate was slightly higher in cases (8%) than in controls (4%) 
producing a slightly elevated odds ratio of smoking for interview compared to registry data. 
The observed indication for a protective effect of maternal vitamin supplements during pregnancy 
is in line with other investigations,19, 37 although recall bias is a concern for all these case-control 
studies using retrospectively collected exposure data (Table 3). This may also be of concern in 
our study, because we had no such data available from the birth registry. Another explanation for 
the observed effect is confounding. Vitamin intake during pregnancy may indicate a healthier 
lifestyle in general. We did not observe an association for maternal intake of vitamin supplements 
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that contained folic acid.38 Non-differential exposure misclassification, however, is a plausible 
explanation since it can be assumed that the mothers were often not aware that the vitamin 
supplements they took contained folic acid. So far, the exact constituents among the 
multivitamins that could confer a protective effect are unknown.19 
Night shift work was proposed as a risk factor for breast and endometrial cancer,39, 40 and is 
classified as a probable carcinogen (class 2A) by the International Agency for Research on 
Cancer’s programme on the evaluation of carcinogenic risks to humans.41 Although we did not 
have a large enough sample to specifically explore shift work at night, we did not see an 
increased risk of any brain tumours for offspring of mothers who reported any shift work (day or 
night) during pregnancy (Table 3). We saw a possible protective association between working, 
and specifically part-time work, during pregnancy and astrocytoma (Table S2) indicating a 
potential “healthy worker” effect.42 This result, however, was not robust. The association was 
found with interview data but disappeared when exposure was assigned using the birth registry 
data. Furthermore, no association was found in the full astrocytoma subset after adjustment for 
confounders (Table S1). 
Strengths and limitations 
In addition to the data obtained through the CEFALO questionnaire, a unique feature of our 
analysis is that we used birth registry data to explore the association between exposures during 
pregnancy and risk of childhood brain tumours, notably recorded before the diagnosis of the 
disease. This was possible in three of the four countries. In the Nordic Countries notification to 
the medical birth registers is mandatory and, for a large part of our study period, also automated. 
All Nordic medical birth registers are considered to be virtually complete.43 Even if birth registry 
data is sometimes also self-reported and subject to error and censoring (e.g. smoking status 
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during pregnancy), data are collected prospectively, thus error cannot be related to health status 
and is expected to be non-differential. Retrospectively collected interview data, on the other hand, 
may result in an overestimation of the risk if cases overestimate their exposure, or in an 
underestimation if cases under-report exposures.  
Interestingly, we noted often very slightly higher concordance for the cases than controls, which 
may indicate some differential exposure misclassification is at play. Since this pattern was mostly 
seen in the very high Kappa range (>0.8), it may also simply indicate that a small proportion of 
control mothers are perhaps less careful or thorough in answering the questionnaire. Either way, 
it indicates the potential for differential exposure misclassification, which might produce biased 
risk estimates.  
Using the international population-based CEFALO study and two independent sources of 
exposure data, we found no consistent associations between a variety of anthropometric factors, 
birth characteristics and exposures during pregnancy and risk of brain tumours among children 
and adolescents. Our comparison of the two sources of exposure data, however, indicates some 
potential for differential exposure misclassification and thus potentially biased risk estimates 
when relying on interview data alone. It is, therefore, reassuring that analyses of factors for which 
birth registry data were available were consistent with the analyses using interview data.  
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Table 1. Characteristics of the study participants 
 Full sample Astrocytoma subset 
  Cases (n=352) Controls (n=646) Cases (n=162) Controls (n=295) 
Characteristic No. (%) No. (%) No. (%) No. (%) 
Country       
Denmark 85 (24.1) 170 (26.3) 41 (25.3) 82 (27.8) 
Sweden 138 (39.2) 228 (35.3) 55 (34.0) 89 (30.2) 
Norway 44 (12.5) 78 (12.1) 23 (14.2) 38 (12.9) 
Switzerland 85 (24.2) 170 (26.3) 43 (26.5) 86 (29.1) 
Age at reference date, years   
   
7-9 88 (25.0) 167 (25.9) 35 (21.6) 65 (22.0) 
10-12 82 (23.3) 151 (23.4) 46 (28.4) 83 (28.1) 
13-15 99 (28.1) 183 (28.3) 43 (26.5) 79 (26.8) 
16-19 83 (23.6) 145 (22.5) 38 (23.5) 68 (23.1) 
Sex         
Female 162 (46.0) 293 (45.4) 86 (53.1) 161 (54.6) 
Male 190 (54.0) 353 (54.6) 76 (46.9) 134 (45.4) 
Gestational age, weeks a   
missing data 118 (33.5) 206 (31.9) 52 (32.1) 104 (35.2) 
<32  1 (0.3) 4 (0.6) 0 (0) 4 (1.4) 
32 - 37 9 (2.6) 14 (2.2) 4 (2.5) 7 (2.4) 
≥37  224 (63.6) 422 (65.3) 106 (65.4) 180 (61.0) 
Educational level b    
   
Low 20 (5.7) 26 (4.0) 12 (7.4) 10 (3.4) 
Intermediate 188 (53.4) 336 (52.0) 85 (52.5) 156 (52.9) 
High 144 (40.9) 279 (43.2) 65 (40.1) 128 (43.4) 
Unknown 0 (0) 5 (0.8) 0 (0) 1 (0.3) 
Notes: 
a. Based on registry data, all other variables based on interview data 
b. Based on highest attained level of either parent. High = graduating from university or technical 
college; Intermediate = elementary school, diploma school, or apprenticeship; and Low = 
elementary school not completed 
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Table 2. Agreement between interview data and birth registry data (Cohen’s Kappa) 
Variable a 
Registry 
Data 
No. 
Overall 
Kappa 
overall 
No. 
Cases 
Kappa 
cases 
No. 
Controls 
Kappa 
controls 
Birth weight b  SE, DK, NO 680 0.98 242 0.99 438 0.98 
Birth length c SE, DK, NO 668 0.92 238 0.95 430 0.91 
Caesarean section SE, DK, NO 352 0.95 135 1.00 217 0.91 
Vacuum extraction SE, DK, NO 464 0.72 169 0.72 295 0.72 
Forceps SE, DK, NO 454 0.85 165 0.89 289 0.83 
Smoking during pregnancy d SE, NO 315 0.77 122 0.75 193 0.79 
Work during pregnancy SE 264 0.54 97 0.61 167 0.50 
Hours worked during pregnancy e SE 262 0.54 97 0.53 165 0.55 
Ever stillbirth/miscarriage SE, DK, NO 252 0.71 85 0.71 167 0.71 
Single or multiple births SE, DK 574 0.96 203 1.00 371 0.94 
Notes: 
a. Weighted kappa was used for ordinal categories: birth weight, birth length, and hours worked 
during pregnancy. All other variables were binary. 
b. Birth weight categories based on definition of low (<2500g) and high (≥4000g) birth weight  
c. Birth length categories defined based on 25th and 75th percentile of birth length for the 
control subjects 
d. Binary response to interview question "did you smoke during pregnancy?" vs. Registry 
question "smoking at first visit to maternity clinic."  
e. Hours worked during pregnancy (full time, part time, not worked) 
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Table 3. Relationship between exposures and brain tumour risk among children and adolescents 
based on interview data  
Variable Cases Controls OR (95%-CI) a OR (95%-CI) a 
  No. No. Unadjusted Adjusted b 
Anthropometric factors:         
Birth weight c         
<2500 g 20 25 1.45 (0.79-2.66) 1.53 (0.83-2.82) 
2500-4000 g 274 508 1.0 1.0 
≥ 4000 g 53 95 1.06 (0.73-1.54) 1.09 (0.74-1.58) 
p value for trend     
 
0.581 
Birth length d         
≤ 49 cm 104 180 1.05 (0.76-1.44) 1.03 (0.75-1.42) 
50-52 cm 163 295 1.0 1.0 
≥ 53 cm 67 122 1.04 (0.72-1.49) 1.04 (0.72-1.49) 
p value for trend     
 
0.744 
Age of the mother         
<25 years 80 120 1.0 1.0 
25-29 131 249 0.81 (0.56-1.16) 0.82 (0.57-1.19) 
30-34 97 181 0.82 (0.56-1.22) 0.85 (0.57-1.26) 
≥ 35 41 85 0.73 (0.46-1.16) 0.74 (0.46-1.18) 
p value for trend     
 
0.158 
Birth characteristics:         
Caesarean section         
No 300 541 1.0 1.0 
Yes 47 86 0.98 (0.66-1.45) 0.99 (0.67-1.48)  
Vacuum extraction         
No 304 541 1.0 1.0 
Yes 40 74 0.99 (0.64-1.52) 0.98 (0.63-1.51) 
Forceps         
No 334 599 1.0 1.0 
Yes 10 16 1.13 (0.49-2.64) 1.11 (0.47-2.61) 
Born premature (at least 3 weeks too early)       
No 318 558 1.0 1.0 
Yes 26 52 0.86 (0.53-1.40) 0.85 (0.52-1.39) 
Ever stillbirth/miscarriage         
No 239 413 1.0 1.0 
Yes 104 196 0.92 (0.69-1.22) 0.92 (0.69-1.23) 
Birth order         
1st born 148 254 1.0 1.0 
≥2nd born 203 385 0.87 (0.67-1.14) 0.90 (0.68-1.20) 
Single or multiple births         
Singleton 342 622 1.0 1.0 
Multiple birth 8 15 1.00 (0.41-2.41) 1.04 (0.43-2.53) 
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Variable Cases Controls OR (95%-CI) a OR (95%-CI) a 
  No. No. Unadjusted Adjusted b 
Exposures:         
Maternal smoking during pregnancy         
No 258 493 1.0 1.0 
Yes 90 133 1.27 (0.94-1.73) 1.23 (0.90-1.68) 
Maternal vitamin intake during pregnancy  
No 189 290 1.0 1.0 
Yes 139 289 0.75 (0.56-1.01) 0.75 (0.56-1.01) 
Maternal vitamin and folic acid intake during pregnancy     
No 230 380 1.0 1.0 
Yes 59 93 1.10 (0.75-1.61) 1.15 (0.78-1.70) 
Work during pregnancy         
No 99 154 1.0 1.0 
Yes 248 471 0.80 (0.59-1.08) 0.82 (0.61-1.12) 
Hours worked during pregnancy         
Not worked 99 154 1.0 1.0 
Part-time (<40 hours/week) 165 313 0.80 (0.58-1.11) 0.84 (0.60-1.17) 
Full time (40 hours/week) 81 149 0.81 (0.55-1.19) 0.83 (0.57-1.23) 
p value for trend     
 
0.255 
Shift work during pregnancy         
Not worked or not shift worked  287 520 1.0 1.0 
Shift worked  59 102 1.00 (0.69-1.45) 0.99 (0.68-1.44) 
Maternal diabetes e         
No 341 610 1.0 1.0 
Yes 6 14 0.76 (0.29-2.00) 0.76 (0.29-2.02) 
Notes: 
a. Conditional logistic regression models, matched on sex, age-group and geographical region  
b. Adjusted for maternal age and parental education 
c. Birth weight categories based on definition of low (<2500g) and high (≥4000g) birth weight  
d. Birth length categories defined based on 25th and 75th percentile of birth length for the control 
subjects 
e. Defined as existing maternal diabetes or maternal gestational diabetes 
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Table 4. Comparison of brain tumour risk among children and adolescents based on interview vs. 
birth registry data, based on the study population where both types of data are available 
  Interview data    Birth Registry data  
Variable Cases Controls OR (95%-CI) a Cases Controls OR (95%-CI) a Registry 
Data 
    No. No. Adjusted b No. No. Adjusted b 
Anthropometric factors:               
Birth weight c             SE, DK, NO 
<2500 g 12 13 1.66 (0.72-3.86) 11 14 1.42 (0.63-3.21)   
2500-4000 g 177 313 1.0 178 313 1.0   
≥ 4000 g 47 71 1.31 (0.85-2.01) 47 70 1.33 (0.86-2.05)   
p value for trend     0.743     0.488   
Birth length d             SE, DK, NO 
≤ 49 cm 58 93 0.96 (0.62-1.48) 59 94 0.96 (0.62-1.48)   
50-52 cm 120 194 1.0 121 193 1.0   
≥ 53 cm 54 97 0.98 (0.64-1.50) 52 97 0.91 (0.59-1.41)   
p value for trend     0.641     0.565   
Head circumference e             SE, DK, NO 
< 38 cm - - - 157 246 1.0   
≥ 38 cm - - - 6 10 1.08 (0.37-3.15)   
Gestational age (per week) e - - - 227 383 1.00 (0.91-1.08) SE, DK, NO 
Birth characteristics:               
Caesarean section             SE, DK, NO 
No 103 159 1.0 103 161 1.0   
Yes 19 26 0.88 (0.44-1.78) 19 24 0.96 (0.47-1.97)   
Vacuum extraction             SE, DK, NO 
No 141 235 1.0 150 241 1.0   
Yes 17 23 1.09 (0.53-2.23) 8 17 0.66 (0.25-1.74)   
No 154 252 1.0 155 254 1.0   
Yes 3 5 0.93 (0.21-4.10) 2 3 1.28 (0.20-8.10)   
Ever stillbirth/miscarriage           SE, DK, NO 
No 45 83 1.0 55 102 1.0   
Yes 24 44 0.91 (0.46-1.80) 14 25 0.94 (0.38-2.33)   
Single or multiple births               
Singleton 194 327 1.0 194 328 1.0 SE, DK 
Multiple birth 4 9 0.84 (0.24-2.94) 4 8 0.92 (0.26-3.34)   
Parity e,f     
 
      DK, NO 
first birth - - - 20 28 1.0   
not first birth - - - 33 67 0.75 (0.33-1.71)   
Exposures:               
Maternal smoking during pregnancy         SE, NO 
No 85 129 1.0 90 127 1.0   
Yes 29 37 1.25 (0.68-2.26) 24 39 0.96 (0.53-1.75)   
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  Interview data    Birth Registry data  
Variable Cases Controls OR (95%-CI) a Cases Controls OR (95%-CI) a Registry 
Data 
    No. No. Adjusted b No. No. Adjusted b 
Work during pregnancy             SE 
No 14 19 1.0 11 14 1.0   
Yes 69 92 0.76 (0.31-1.86) 72 97 0.77 (0.30-1.95)   
Hours worked during pregnancy           SE 
Not worked 14 19 1.0 11 14 1.0   
Part-time (<40 hours/week) 38 41 0.92 (0.35-2.42) 30 40 0.77 (0.29-2.06)  
Full time (40 hours/week) 31 50 0.68 (0.27-1.73) 42 56 0.78 (0.29-2.08)   
p value for trend     0.160     0.292   
Notes: 
a. Conditional logistic regression models, matched on sex, age-group and geographical region  
b. Adjusted for maternal age and parental education 
c. Birth weight categories based on definition of low (<2500g) and high birth weight (>= 4000g) 
d. Birth length categories defined based on 25th and 75th percentile of birth length for the control 
subjects 
e. Head circumference, gestational age and parity were not inquired in the interview 
f. Parity adjusted for maternal age only 
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Table S1. Relationship between exposures and astrocytoma risk among children and adolescents 
based on interview data  
Variable Cases Controls OR (95%-CI) a OR (95%-CI) a 
  No. No. Unadjusted Adjusted b 
Anthropometric factors:         
Birth weight c         
<2500 g 9 18 0.81 (0.35-1.90) 0.84 (0.35-1.99) 
2500-4000 g 129 222 1.0 1.0 
≥ 4000 g 22 46 0.84 (0.48-1.47) 0.90 (0.51-1.59) 
p value for trend       0.711 
Birth length d         
≤ 49 cm 54 84 1.16 (0.74-1.80) 1.10 (0.70-1.74) 
50-52 cm 71 135 1.0 1.0 
≥ 53 cm 30 53 1.06 (0.62-1.80) 1.05 (0.61-1.80) 
p value for trend       0.640 
Age of the mother         
<25 years 33 47 1.0 1.0 
25-29 62 120 0.75 (0.42-1.31) 0.85 (0.47-1.51) 
30-34 45 83 0.83 (0.45-1.51) 0.93 (0.50-1.72) 
≥ 35 20 39 0.72 (0.36-1.45) 0.77 (0.38-1.57) 
p value for trend       0.380 
Birth characteristics:         
Caesarean section         
No 132 245 1.0 1.0 
Yes 28 40 1.26 (0.73-2.15) 1.28 (0.74-2.23)  
Vacuum extraction         
No 138 243 1.0 1.0 
Yes 19 33 1.05 (0.56-1.97) 1.08 (0.57-2.03) 
Forceps         
No 150 267 1.0 1.0 
Yes 7 9 1.54 (0.51-4.62) 1.43 (0.47-4.39) 
Born premature (at least 3 weeks too early)       
No 147 251 1.0 1.0 
Yes 12 26 0.77 (0.38-1.54) 0.78 (0.38-1.58) 
Ever stillbirth/miscarriage         
No 110 193 1.0 1.0 
Yes 48 83 1.02 (0.67-1.57) 1.01 (0.65-1.56) 
Birth order         
1st born 71 125 1.0 1.0 
≥2nd born 91 167 0.96 (0.65-1.41) 0.97 (0.64-1.47) 
Single or multiple births         
Singleton 158 282 1.0 1.0 
Multiple birth 4 10 0.74 (0.22-2.47) 0.84 (0.25-2.88) 
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Variable Cases Controls OR (95%-CI) a OR (95%-CI) a 
  No. No. Unadjusted Adjusted b 
Exposures:     
Maternal smoking during pregnancy     
No 120 227 1.0 1.0 
Yes 41 58 1.34 (0.84-2.13) 1.26 (0.78-2.04) 
Maternal vitamin intake during pregnancy  
No 83 132 1.0 1.0 
Yes 65 129 0.81 (0.52-1.27) 0.76 (0.48-1.20) 
Maternal vitamin and folic acid intake during pregnancy     
No 105 178 1.0 1.0 
Yes 29 38 1.34 (0.75-2.40) 1.41 (0.77-2.58) 
Work during pregnancy         
No 56 78 1.0 1.0 
Yes 104 206 0.65 (0.42-1.01) 0.70 (0.45-1.09) 
Hours worked during pregnancy         
Not worked 56 78 1.0 1.0 
Part-time (<40 hours/week) 74 143 0.67 (0.41-1.08) 0.75 (0.46-1.24) 
Full time (40 hours/week) 29 59 0.66 (0.38-1.17) 0.70 (0.39-1.24) 
p value for trend       0.130 
Shift work during pregnancy         
Not worked or not shift worked  146 242 1.0 1.0 
Shift worked  14 42 0.50 (0.26-0.95) 0.52 (0.27-1.01) 
Maternal diabetes e         
No 155 279 1.0 1.0 
Yes 5 4 2.33 (0.62-8.72) 2.80 (0.72-10.93) 
Notes: 
a. Conditional logistic regression models, matched on sex, age-group and geographical region  
b. Adjusted for maternal age and parental education 
c. Birth weight categories based on definition of low (<2500g) and high (≥4000g) birth weight  
d. Birth length categories defined based on 25th and 75th percentile of birth length for the control 
subjects 
e. Defined as existing maternal diabetes or maternal gestational diabetes 
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Table S2. Comparison of astrocytoma risk among children and adolescents based on interview vs. 
birth registry data based on the study population, where both types of data are available 
  Interview data    Birth Registry data  
Variable Cases Controls OR (95%-CI) a Cases Controls OR (95%-CI) a Registry 
Data 
    No. No. Adjusted b No. No. Adjusted b 
Anthropometric factors:               
Birth weight c             SE, DK, NO 
<2500 g 5 10 0.70 (0.21-2.37) 4 11 0.57 (0.17-1.86)   
2500-4000 g 83 137 1.0 84 137 1.0   
≥ 4000 g 19 32 1.18 (0.60-2.34) 19 31 1.20 (0.60-2.42)   
p value for trend     0.894     0.629   
Birth length d       SE, DK, NO 
≤ 49 cm 29 45 0.84 (0.43-1.64) 31 45 0.99 (0.51-1.93)   
50-52 cm 51 82 1.0 49 83 1.0   
≥ 53 cm 24 41 0.98 (0.52-1.86) 24 40 1.07 (0.56-2.06)   
p value for trend     0.544     0.477   
Head circumference e             SE, DK, NO 
< 38 cm - - - 71 109 1.0   
≥ 38 cm - - - 3 6 1.03 (0.24-4.42)   
Gestational age (per week) - - - 106 179 1.02 (0.91-1.15) SE, DK, NO 
Birth characteristics:         
Caesarean section 40 65 1.0 40 65 1.0 SE, DK, NO 
No 12 13 1.24 (0.40-3.82) 12 13 1.24 (0.40-3.82)   
Yes               
Vacuum extraction 57 98 1.0 61 100 1.0 SE, DK, NO 
No 8 9 1.13 (0.34-3.75) 4 7 0.84 (0.19-3.68)   
Yes               
No 64 104 1.0 64 105 1.0   
Yes 1 3 0.53 (0.05-5.36) 1 2 0.98 (0.08-11.55)   
Ever stillbirth/miscarriage           SE, DK, NO 
No 24 41 1.0 26 48 1.0   
Yes 8 18 0.71 (0.23-2.19) 6 11 0.83 (0.22-3.13)   
Single or multiple births               
Singleton 85 146 1.0 85 146 1.0 SE, DK 
Multiple birth 3 5 1.03 (0.21-5.13) 3 5 1.03 (0.21-5.13)   
Parity e,f             DK, NO 
first birth - - - 12 16 1.0   
not first birth - - - 17 33 0.73 (0.22-2.41)   
Exposures:         
Maternal smoking during pregnancy         SE, NO 
No 34 51 1.0 37 49 1.0   
Yes 13 17 0.97 (0.35-2.68) 10 19 0.59 (0.22-1.58)   
Work during pregnancy             SE 
No 9 5 1.0 7 1 1.0   
Yes 22 35 0.14 (0.02-0.97) 24 39 0.14 (0.01-1.29)   
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  Interview data    Birth Registry data  
Variable Cases Controls OR (95%-CI) a Cases Controls OR (95%-CI) a Registry 
Data 
    No. No. Adjusted b No. No. Adjusted b 
Hours worked during pregnancy           SE 
Not worked 9 5 1.0 7 1 1.0   
Part-time (<40 hours/week) 11 18 0.09 (0.01-0.97) 9 17 0.13 (0.01-1.29)  
Full time (40 hours/week) 11 17 0.15 (0.02-1.06) 15 22 0.15 (0.01-1.43)   
p value for trend     0.073     0.035   
Notes: 
a. Conditional logistic regression models, matched on sex, age-group and geographical region  
b. Adjusted for maternal age and parental education 
c. Birth weight categories based on definition of low (<2500g) and high birth weight (>= 4000g) 
d. Birth length categories defined based on 25th and 75th percentile of birth length for the control 
subjects 
e. Head circumference and parity were not inquired in the interview 
f. Parity adjusted for maternal age only 
